Verdi Oncology Tennessee, Scri Oncology Partners — Nashville, Tennessee

Verdi Oncology Tennessee, Scri Oncology Partners is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Verdi Oncology Tennessee, Scri Oncology Partners has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Solid Tumor, Adult, Refractory Cancer, Endometrial Carcinoma (EC).

Sponsors: GV20 Therapeutics.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Verdi Oncology Tennessee, Scri Oncology Partners?

Verdi Oncology Tennessee, Scri Oncology Partners has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Verdi Oncology Tennessee, Scri Oncology Partners conducted?

Verdi Oncology Tennessee, Scri Oncology Partners has 1 clinical trials on record, with 1 currently active. Their work covers Solid Tumor, Adult, Refractory Cancer, Endometrial Carcinoma (EC).

Is Verdi Oncology Tennessee, Scri Oncology Partners accredited by Crixeo Health?

Verdi Oncology Tennessee, Scri Oncology Partners has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Verdi Oncology Tennessee, Scri Oncology Partners?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.